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Abstract
Background:  N,N-Diethyl-3-methylbenzamide (deet) remains the gold standard for insect
repellents. About 200 million people use it every year and over 8 billion doses have been applied
over the past 50 years. Despite the widespread and increased interest in the use of deet in public
health programmes, controversies remain concerning both the identification of its target sites at
the olfactory system and its mechanism of toxicity in insects, mammals and humans. Here, we
investigated the molecular target site for deet and the consequences of its interactions with
carbamate insecticides on the cholinergic system.
Results: By using toxicological, biochemical and electrophysiological techniques, we show that
deet is not simply a behaviour-modifying chemical but that it also inhibits cholinesterase activity, in
both insect and mammalian neuronal preparations. Deet is commonly used in combination with
insecticides and we show that deet has the capacity to strengthen the toxicity of carbamates, a class
of insecticides known to block acetylcholinesterase.
Conclusion: These findings question the safety of deet, particularly in combination with other
chemicals, and they highlight the importance of a multidisciplinary approach to the development of
safer insect repellents for use in public health.
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Background
The use of repellents against biting arthropods was prob-
ably developed a thousand years ago [1]; however, a real
breakthrough occurred in 1953 with the discovery of the
synthetic repellent N,N-Diethyl-3-methylbenzamide
(deet), which became the most commonly used active
ingredient of topically applied insect repellent due to its
efficacy against a broad spectrum of medically important
pests, including mosquitoes [2]. Despite the widespread
and increased interest in the use of deet in public health
programmes [3-5], controversies remain concerning both
the identification of its target sites at the molecular level
and its exact mechanism of action in insects. Ditzen and
colleagues [6] suggested that deet may block electrophys-
iological responses of olfactory sensory neurons to attrac-
tive odours in Anopheles gambiae Giles (Diptera:Culicidae)
and Drosophila melanogaster Meigen (Diptera:Drosophili-
dae). By contrast, Syed and Leal [7] have recently reported
that mosquitoes detect deet by means of olfaction, a phys-
iological mechanism that directly initiates avoidance
behaviour (i.e., deet does not cause a loss of attractive
chemical signal).
Although the debate concerning the 'olfactory' mode of
action of deet is still a topical question, other laboratory
bioassays and field experiments have revealed that deet
also exerts a deterrent effect in insects and has insecticidal
properties [8-10]. In the same context, if deet is consid-
ered to have a relatively good toxicological profile [11],
other authors have shown that excessive doses of deet
could be toxic to humans and could cause severe seizures
and lethality when combined with other active ingredi-
ents, such as pesticides [12-14]. It has been reported pre-
viously that symptoms related to deet poisoning in
invertebrates, mammals and humans reflect an apparent
action on the central nervous system (CNS) [15-18].
Based on these findings, we have investigated further the
potential mechanisms of deet toxicity. For the first time,
we have identified a molecular target site for deet (i.e.,
cholinesterases) in both insect and mammal neuronal
preparations, and have investigated the consequences of
its interactions with carbamate insecticides on the cholin-
ergic system.
Results and discussion
Insecticidal effect of deet on insects
To elucidate repellent toxicity in insects, we first assessed
the sensitivity of the dengue vector Aedes aegypti L. (Dip-
tera:Culicidae) to deet -treated filter papers using World
Health Organization (WHO) bioassays [19]. Figure 1
shows that deet caused dose-dependent mortality at doses
ranging from 400 to 1200 μg/cm2 [4,20]. This range corre-
sponds to the lower range of doses usually applied to
human skin for personal protection. Topical applications
of deet on the mosquito Culex pipiens quinquefasciatus Say
(Diptera:Culicidae) resulted in an LD50 (lethal dose for
50% of exposed mosquitoes) and an LD90 of deet for adult
females of 393.3 ± 25.4 (standard error of the mean;
s.e.m.) and 1103.0 ± 25.4 ng of active ingredient/mg of
mosquito (ng a.i./mg, respectively). For comparison, the
LD50 and LD90 of propoxur (2-(1-Methylethoxy) phenol
methylcarbamate) were 2.6 ± 0.2 and 10.5 ± 1.6 ng a.i./
mg female, respectively, indicating that the amount of
deet required to kill mosquitoes was about 150 times
higher than that for propoxur, an acetylcholinesterase
(AChE, EC 3.1.1.7) inhibitor. However, the slopes of the
regression lines for mosquito mortality for deet (3.67 ±
0.85) and propoxur (3.35 ± 0.50) did not differ signifi-
cantly. This indicated a similar heterogeneity of response
by the mosquitoes with respect to the toxic effect of the
two molecules.
Neurophysiological effects of deet on insect and 
mammalian neuronal preparations
Based on these observations, we investigated the neuro-
physiological effects of deet on the cercal-afferent giant-
interneuron synapses in the terminal abdominal ganglion
of the cockroach Periplaneta americana L. (Dyctioptera:
Blattidae), known to present many functional analogies
with other insect systems [21]. The single-fibre oil-gap
method [22] is a well-adapted electrophysiological tech-
nique for the cockroach CNS, which allows investigation
of the effects of such compounds at the synaptic level.
Deet dissolved in physiological saline was applied at two
concentrations (0.5 and 1 μM) on the synaptic prepara-
tion by superfusion into the experimental chamber. Bath
application of deet produced a biphasic effect on excita-
tory post synaptic potential (EPSP) amplitudes. As illus-
trated in Figure 2a (blue bars), deet (1 μM) produced an
increase in EPSP amplitude within the first 3 min (118 ±
4% s.e.m., F1.18 = 29, P < 0.001, n = 10, Figure 2a). This
effect was also observed at 0.5 μM deet (113 ± 5% s.e.m.
at 0.5 μM, F1.14 = 32, P < 0.001, n = 8). After 3 min, a time-
dependent decrease in EPSP amplitude was observed
compared with controls, which was more pronounced
with the higher concentration (77 ± 6% after 30 min, F1.12
= 26, P < 0.001, n = 6, Figure 2a). This typical biphasic
effect, previously observed with anticholinesterase com-
pounds such as carbamates [23], reflected changes in syn-
aptic transmission activity. Indeed, treatment with
carbamates can cause an increase in acetylcholine (ACh)
concentration that is sufficient to activate negative feed-
back acting through presynaptic muscarinic receptors,
which thereby decrease subsequent release of ACh
[23,24]. As the deet-induced biphasic effect on EPSP
amplitude was very similar to that reported with classical
anticholinesterase compounds, it is possible that deet
might cause an elevation of ACh concentration into the
synaptic cleft via an inhibition of AChE. To test this
hypothesis, we conducted additional experiments in theBMC Biology 2009, 7:47 http://www.biomedcentral.com/1741-7007/7/47
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presence of atropine, known to block muscarinic recep-
tors in insect synaptic transmission [24]. As illustrated in
Figure 2a (red bars), pre-treatment with atropine (1 μM)
for 10 min counteracted the EPSP depression previously
observed with deet, producing only a time-dependent
increase in EPSP amplitude (for example, 142 ± 4% after
30 min exposure to 1 μM deet, F1.18 = 27, P < 0.001, n =
10). These data confirm the participation of pre-synaptic
muscarinic receptors in the modulation of ACh release in
the synapses after bath application of deet [24]. It is also
interesting to note that application of deet on synaptic
preparations, pre-treated with 1 μM atropine, increased
both composite (Figure 2b) and unitary EPSP amplitudes
(Figure 2c), which result from the spontaneous activity of
presynaptic cercal mechanoreceptors. All these findings
clearly indicate that ACh is not efficiently hydrolyzed by
AChE in the presence of deet.
Based on these unexpected results and because AChE is an
ubiquitous enzyme in both insect and mammalian nerv-
ous systems, additional electrophysiological studies were
performed on isolated mouse phrenic hemidiaphragm
muscles. We showed that 500 μM deet prolonged by
about threefold the decay time constant of synaptic poten-
tials on endplate regions of the muscle fibre (Figure 2d).
This prolongation of the time course of synaptic poten-
tials, which is known to occur after AChE inhibition
[25,26] or in the absence of AChE expression [27], was
shown to be due to the lack of ACh hydrolysis, allowing
ACh to persist in the synaptic cleft and to activate endplate
nicotinic ACh receptors repeatedly. Considering our data,
higher concentrations of deet were, however, required to
prolong the decay time constant of synaptic events on
mammalian neuromuscular preparations (500 μM) com-
pared with cockroach synaptic preparations (1 μM).
Characterization of cholinesterase inhibition by deet
To ascertain the inhibition of cholinesterases by deet, we
analysed, in vitro, the effect of deet on the activity of puri-
fied AChE from D. melanogaster (DmAChE) and both
acetyl and butyrylcholinesterases (EC 3.1.1.8) from
human (HuAChE and HuBChE). As illustrated in Figures
3a, b, and 3c, incubation of each enzyme with the sub-
strate and deet (from 1 to 10 mM) resulted in a strong
reduction of enzyme activity. This indicates that deet is
capable of inhibiting the hydrolysis of acetylthiocholine
(ATCh) and butyrylthiocholine (BTCh) by AChEs. As pre-
incubation of the enzyme with deet in the absence of sub-
strate did not change the extent of inhibition, and as
dilution of the inhibited enzyme restored enzyme activity,
Deet can be considered as a reversible inhibitor of
cholinesterases. Deet has also the capacity to diminish the
rate of AChE carbamoylation by propoxur (Figures 3d and
3e), indicating that both molecules act as competitive
inhibitors for the enzyme.
The kinetics of substrate hydrolysis by cholinesterases are
complex. The substrate first binds to a peripheral site,
located at the entrance of the active site gorge, and then
slides down to the catalytic site, buried 20 Å inside the
protein (Additional file 1). Simultaneous kinetic analyses
of inhibition of substrate hydrolysis and carbamoylation
allowed us to estimate the binding constants of DEET for
the two substrate binding sites of cholinesterases. Binding
of deet at the peripheral site was estimated to be 1.02 ±
0.03, 8.39 ± 6.97 and 0.37 ± 0.05 mM for DmAChE,
HuAChE and HuBChE, respectively (Table 1). Binding of
deet at the catalytic site located at the bottom of the active
site gorge was not necessary to describe inhibition of
DmAChE and was estimated as 4.67 and 1.08 mM for
HuAChE and HuBChE, respectively (Table 1). Thus, deet
would enter into the active site gorge of HuAChE and
HuBChE, but not that of DmAChE, resulting in a stronger
inhibition of human enzymes. This hypothesis was con-
sistent with structural data showing the active site gorge of
DmAChE to be about 50% narrower than the active site of
HuAChE [28]. To determine whether the accommodation
and binding of deet was possible within the active site of
Insecticidal effect of deet on mosquitoes Figure 1
Insecticidal effect of deet on mosquitoes. a) Mortality 
rate among A. aegypti exposed for 1 h to paper impregnated 
with deet in World Health Organisation bioassays. Doses 
applied on paper were compared with standard skin applica-
tions of commercially available formulations containing deet 
(lower and upper deet formulation concentrations 5 to 100% 
were taken from the review of Xue et al. [20]). Deet formu-
lation concentrations (%) were converted to doses (μg/cm2) 
based on 5 ml being the average volume required to cover a 
human arm [4]. The figure showed that the doses used on 
skin (400 μg/cm2 to 8000 μg/cm2) were equivalent or greater 
than doses showing insecticidal properties in the case of 
close contact (LD50 = 830 ± 30 μg/cm2, s.e.m; LD95 = 1,180 ± 
50 μg/cm2).
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Effects of deet on insect and mammalian neuronal preparations Figure 2
Effects of deet on insect and mammalian neuronal preparations. a) The Histogram illustrates the excitatory postsyn-
aptic potential (EPSP) amplitudes (% of control) versus time (min) after exposure to 1 μM of deet in absence (blue bars) and in 
the presence of atropine (red bars) in P. americana central nervous system. Application of deet without atropine (blue bars) 
induced a biphasic effect on EPSP amplitudes. Within the first 3 min, application of deet induced a significant increase of EPSP 
amplitude which reflected an elevation of acetylcholine (ACh) concentration in the synaptic cleft (see text for details). After 3 
min, a significant EPSP depression was observed, suggesting a regulation of ACh concentration in the synaptic cleft through an 
activation of presynaptic muscarinic receptors. Pre-treatment for 10 min with atropine 1 μM (red bars) clearly reversed the 
EPSP depression observed with deet 1 μM, confirming the participation of the muscarinic receptors in the negative feedback of 
ACh release following deet exposure. Data are means ± S.E.M. b) and c) Typical examples of cockroach composite (b) and 
unitary (c) EPSP following deet application. Experiments were done in the presence of atropine (1 μm) to prevent an action of 
presynaptic muscarinic receptors. Note the increase of unitary EPSP frequency and amplitude (c) following deet application 
(0.5 μM) in the synapses. d) Effect of deet on the time course of full size endplate potentials (EPPs) recorded in a mouse hemid-
iaphragm preparation bathed with a standard Krebs-Ringer solution supplemented with 1.6 μM μ-conotoxin GIIIB to selec-
tively block sodium channels in muscle fibres. The EPPs recorded under control conditions (trace 1), and after the addition of 
500 μM deet to the medium (trace 2); note the prolongation of the decay phase of EPPs in the presence of deet, with little 
change in the amplitude and time to peak; the mean decay-time constant were 11.1 ± 0.7 and 3.8 ± 0.08 ms for deet-treated 
and controls, respectively (n = 6, P < 0.001).BMC Biology 2009, 7:47 http://www.biomedcentral.com/1741-7007/7/47
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Effects of deet on cholinesterase enzymatic activities Figure 3
Effects of deet on cholinesterase enzymatic activities. a) and b) Inhibition of D. melanogaster (a) and Human (b) acetyl-
cholinesterases (AChEs) by deet. Note the dose-dependant decrease of ATCh hydrolysis by AChE following deet application. 
[ATCh]: Acetylthiocholine concentration in micromole per liter; v/[Et] specific activity in s-1. c) Inhibition of human (Hu) 
butyrylcholinesterase by deet. As previously observed with ATCh, deet is also capable of strongly decreasing the BTCh hydrol-
ysis by human BChE. [BTCh]: butyrylthiocholine concentration in micromole per liter; v/[Et] specific activity in s-1. d and e) 
Dose-dependant effect of deet on Drosophila (d) and Human (e) AChE carbamoylation rates by propoxur (carbamate). The 
curves clearly show the strong reduction of the second order rate constant (ki) for the carbamoylation of HuAChE by pro-
poxur in presence of deet. At high concentration (10 mM), protection of AChE by deet is total. f) Accommodation and binding 
of deet inside the active site of Human AChE. The picture was created by VMD, a Visual Molecular Dynamics program. After 
QMMM relaxation of the complex between HuAChE and deet molecule, the latter was accommodated in a tetrahedral adduct 
conformation. Minimal adaptation of the side chains of adjacent residues in the active side of HuAChE suggests that the accom-
modation of deet in a position favourable for enzymatic hydrolysis is possible.
    






5HI GHHWP0 GHHWP0 GHHWP0
>$7&K@0
Y

(
W


V
H
F



    




N
L


0



P
L
Q



    




N
L


0



P
L
Q



>GHHW@P0
D E
         




5HI GHHWP0 GHHWP0
>$7&K@0
Y

(
W


V
H
F



         




GHHWP0

   






GHHWP0 GHHWP0
>%X7&K@0
Y

(
W


V
H
F



5HI
      





>GHHW@
N
L


0




P
L
Q



      





P0
N
L


0




P
L
Q



F G
H I
DEETBMC Biology 2009, 7:47 http://www.biomedcentral.com/1741-7007/7/47
Page 6 of 11
(page number not for citation purposes)
vertebrate AChE, it was docked as a tetrahedral adduct on
the catalytic serine of human AChE crystal structure
(1B41). Minimal adaptation of the side chains of adjacent
residues in the active side of HuAChE suggests the accom-
modation of deet in a catalytic site is possible (Figure 3f).
Interactions between deet and cholinesterase compounds
Having established that deet binds to the active site of
cholinesterases and then hinders the entrance of sub-
strates, we investigated its potential interaction with car-
bamate insecticides. The effects of topical applications of
a range of deet doses combined with a range of propoxur
doses applied to C. quinquefasciatus were not in agreement
with a model based on the hypothesis of an additive effect
for the two compounds (Figure 4a). Several models of
interactions between the two chemicals were subse-
quently tested. The best fit took into account a synergistic
interaction involving the effect of deet on the insecticidal
effect of propoxur (Figure 4b). Further electrophysiologi-
cal experiments were conducted on P. americana prepara-
tions to assess deet and propoxur interactions at the
synaptic level (Figure 4c). After pre-treatment of atropine
and when applied alone, both propoxur (P) and deet (D1
and D2) significantly increased EPSP amplitude com-
pared with the control (P < 0.01 and P < 0.001, respec-
tively). In the presence of atropine, however, subsequent
application of deet + propoxur (P+D) did not cause a
greater effect on post-synaptic potentials than that caused
by deet alone at the same concentrations. Propoxur+D1
was almost equal to D1; the difference between them was
not significant (F1.16 = 0, P < 0.95, n = 8). Similarly, there
was no difference between P+D2 and D2 (F1.16 = 0, P <
0.92, n = 8). This indicates that propoxur and deet acted
similarly on the same target site in the insect cholinergic
system.
However, a different trend was noted on mouse isolated
phrenic hemidiaphragm muscles. Indeed, when neostig-
mine (3 μM) was perfused in the continuous presence of
500  μM deet, the decay time constant of synaptic
responses was about two fold more prolonged than with
deet alone (Figure 4d). Recordings of full (maximum) size
endplate potentials (EPPs) in response to a single or
paired nerve stimuli, either in the presence of 500 μM deet
or in the presence of deet plus 3 μM neostigmine, showed
a marked prolongation of the decay phase of the EPPs in
the presence of deet and neostigmine (Figure 4e). These
results indicated that deet (i) had an inhibitory action on
AChE in mouse hemidiaphragm endplates that was not
maximal at the concentration used; (ii) did not prevent
subsequent action of neostigmine on endplate AChE; and
(iii) was less active, on an equimolar basis, than neostig-
mine in mouse hemidiaphragm junctions. We have
shown that deet causes an equal or even greater in vitro
inhibitory effect on purified human enzyme than on
insect AChE, and therefore speculate that deet may be a
less potent inhibitor of the asymmetric forms of AChEs,
which are anchored to the basal lamina of the mouse skel-
etal neuromuscular junction[29];
Conclusion
In vivo toxic interactions between deet and propoxur, pir-
imiphos-methyl, or pyridostigmine bromide (PB) for
cockroaches and mosquitoes have been reported previ-
Table 1: Characteristic kinetic constants for the hydrolysis of ATCh and BTCh by DmAChE, HuAChE and HuBChE
DmAChE (ATCh) HuAChE (ATCh) HuBChE (BTCh)
Substrate
k3 [s-1] 395.4 13471 ± 2171 1082 ± 44
Kip [mM] 0.17 5.43 ± 1.0 11.3 ± 0.5
KL 4.17 0.0181 ± 0.0054 0.0019 ± 0.0008
KLL 179 9.23 ± 6.58 12.3 ± 5.4
k2 [s-1] 53465 14375 ± 2182 420 ± 20
A 3.44 1.64 ± 0.36 1.32 ± 0.07
B 0.049 0.11 ± 0.03 39.6 ± 13.5
Ks = Kp*KL [mM] 0.73 0.098 0.021
Kss = Kp*KLL [mM] 31.1 50.1 139
DEET
Kip [mM] 1.02 ± 0.03 8.39 ± 6.97 0.37 ± 0.05
KiL 0.083 ± 0.078 1.54 ± 0.45
KiLL 0.56 ± -0.41 29 ± 5.4
c 1.49 ± 0.99 1.32
d 0.19 ± 0.18 0.52 ± 0.09
Kis = Kip*KiL [mM] 0.69 0.57
Kiss = Kip*KiLL [mM] 4.67 1.08
ATCh = acetylthiocholine; BTCh = butyrylthiocholine; DmAChE = Acetylcholinesterase from D. melanogaster; HuAChE = Acetylcholinesterase 
from human; HuBChE = Butyrylcholinesterase from human.BMC Biology 2009, 7:47 http://www.biomedcentral.com/1741-7007/7/47
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ously [8,30,31]. In adult hens, Abou-Donia et al. [18]
demonstrated that co-exposure to sub-neurotoxic doses of
PB, deet and chlorpyrifos resulted in increased toxicity
characterized by neurological dysfunction and neu-
ropathological lesions. In the central cholinergic system
of rats, application of physiologically relevant doses of
pyridostigmine and deet, in combination, led to neurobe-
havioural deficits and region-specific alterations in AChE
and nicotinic receptors [32]. More investigations are
urgently needed to confirm or dismiss the potential neu-
rotoxicity to humans arising from the combined use of
deet with different cholinesterase inhibitors.
Methods
Toxicological studies
Biological materials
The standard insecticide susceptible strains 'S-Lab' of C.
quinquefasciatus and 'Bora' of A. aegypti were used in bio-
assays. These two strains have been colonized for many
years at IRD-LIN in Montpellier and are free of any detect-
able insecticide resistance mechanisms.
Topical applications
Topical solutions were first prepared by dissolving techni-
cal grade deet 97% (Sigma-Aldrich, Saint Quentin Falla-
vier, France) and/or propoxur 99.6% (Bayer CropScience,
Monheim, Germany) in acetone. For each compound,
five to eight doses were used to provide a range of mortal-
ity from 0 to 100%. Two-to-five-day-old non-blood-fed
females of C. quinquefasciatus were first anaesthetised by
extended contact with carbon dioxide then placed on a
refrigerated plate at 4°C to maintain anaesthesia during
manipulation [19]. A volume of 0.1 μl of insecticide solu-
tion (at the required concentration) was deposited on the
upper part of the pronotum of females using a micro-cap-
illary. Females receiving a volume of 0.1 μl pure acetone
served as controls. After each test, females were transferred
into plastic cups and provided with 10% honey solution
on cotton wool and held for 24 h at 27°C and 80% rela-
tive humidity. Mortality rates were recorded 24 h after the
tests. Data were analysed with the program Global Opti-
mization by Simulated Annealing (GOSA) [33]using the
statistical approach according to Finney [34]. Mortality (y)
as a function of deet doses (x) was fitted to the cumulative
Gauss function and was expressed in nanograms of insec-
ticide per milligram of female weight.
Treated filter papers bioassay
Mortality resulting from tarsal contact with treated filter
paper was measured using WHO test kits [19] against
adult females of A. aegypti. Four batches of 25 non-blood-
fed females, two to five days old, were introduced into
WHO bioassay holding tubes for a period of 60 min. They
were then transferred to exposure tubes, which were held
vertically for 60 min under subdued light. Mortality was
recorded 24 h after exposure. Each solution was tested
four times and each test was replicated three times with
different cohorts of insects to take into account inter-
batch variability.
Electrophysiology
Insect preparations
Adult male cockroaches P. americana were taken from our
laboratory stock colonies which are maintained under
standard conditions (29°C photo-cycle 12 h light/12 h
dark). Cockroaches were pinned dorsal side up in a dissec-
tion dish and dorsal cuticles were removed to allow access
to the ventral nerve cord. The terminal abdominal gan-
glion (TAG) with the nerve cord were carefully dissected
and placed in normal cockroach saline containing (in
mM): NaCl 208, KCl 3.1, CaCl2 10, sucrose 26, 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES)
10; pH was adjusted to 7.2 with NaOH. The synaptic prep-
aration was composed of a cercus, the corresponding cer-
cal nerve XI, the de-sheathed TAG (containing the studied
synapse) and the abdominal part of the nerve cord. Elec-
trophysiological recordings of synaptic events were
obtained using the single-fibre oil-gap method [22]. With
this technique it is possible to record unitary excitatory
postsynaptic potentials (uEPSP) resulting from the activ-
ity of pre-synaptic cercal mechanoreceptors and compos-
ite EPSP. These potentials were triggered in response to
short electrical pre-synaptic stimulation applied at a fre-
quency of 0.1 Hz to the ipsilateral cercal nerve XI and are
the main subject of observations to study synaptic trans-
mission. During experiments, the resting potential was
continuously monitored on a pen chart recorder. The uEP-
SPs and EPSPs were recorded using a Hameg oscilloscope
and stored on a PC computer with Hameg software.
Experiments were conducted at room temperature
(20°C). Data were expressed as a mean ± s.e.m. when
quantified. Electrophysiological data were analysed for
statistical significance using a one-way Analysis of Vari-
ance (ANOVA) followed by a post-hoc Tukey test. Differ-
ences among data were judged to be significant when P <
0.05. Data analysis was performed using STATISTICA
(StatSoft, Cracow, Poland).
In all electrophysiological experiments, deet and pro-
poxur were prepared in dimethylsulfoxide (DMSO, stock
solution 10 mM) and absolute ethanol (stock solution 10
mM), respectively. Final dilutions in physiological saline
contained at most 0.1% DMSO and absolute ethanol.
These concentrations of solvents had no effect on synaptic
transmission. All compounds used were purchased from
Sigma Chemicals (L'isle d'Abeau Chesnes, France) and
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Interactions between deet and anti-cholinesterasic compounds Figure 4
Interactions between deet and anti-cholinesterasic compounds. a) and b) Toxic interactions between deet (μg/mg 
mosquito) and propoxur (μg/mg mosquito) for C. quinquefasciatus by topical application. The model including a synergistic 
interaction (b) between the two molecules provided a better description of the data than a model based on simply additive 
effects (a); see equations   where ED is the effective dose, D the dose and ic the 
interaction coefficient. The interaction coefficient (ic = 3.07 ± 0.98) was significantly greater than 0, indicating that deet syner-
gised propoxur toxicity in insects. c) Effects of propoxur (P) and deet (D), alone and in combination (P+D), on cockroach syn-
aptic activity. All synaptic preparations were pretreated (10 min) with atropine (1 μM). NS not significant (P > 0.05). d) Effect 
of deet and neostigmine on the time course of full size EPPS recorded in mouse hemidiaphragm preparations. Mean values (± 
s.e.m, n = 6) of the half-decay time of EPPs (ms) under control conditions (2.8 ± 0.05 ms, blue column), 500 μM deet (6.1 ± 
0.36 ms, red column) and in the continuous presence of deet and 3 μM neostigmine (10.5 ± 0.55 ms, yellow column). * denotes 
a significant difference from controls (P < 0.001). e) Examples of full size endplate potentials (EPPs) in response to a single or 
paired stimulus in the presence of 500 μM deet and in the presence of deet (upper part) and 3 μM neostigmine (lower part). * 
denote significant difference from control P < 0.001.
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propoxur was bought from Bayer AG (Leverkusen, Ger-
many).
Mammalian preparations
All experiments on mice were performed in accordance
with French and European Community guidelines for lab-
oratory animal handling [35]. Adult male Swiss-Webster
mice (20 to 25 g body weight) purchased from IFFA
CREDO (Saint Germain sur l'Arbresle, France) were
anaesthetized with Isoflurane (AErrane®, Baxter S.A., Less-
ines, Belgium) inhalation, and euthanized by dislocation
of the cervical vertebrae followed by immediate exsan-
guination. The left mouse hemidiaphragm with its associ-
ated phrenic nerve was dissected out from the animal and
mounted in a silicone-lined organ bath (4 ml volume).
Isolated preparations were perfused with standard Krebs-
Ringer solution of the following composition: 154.0 mM
NaCl, 5.0 mM KCl, 2 mM CaCl2, 1.0 mM MgCl2, 5.0 mM
HEPES, and 11.0 mM glucose. The solution gassed with
pure O2 had a pH of 7.4.
Electrophysiological recordings on isolated phrenic
hemidiaphragm muscles were performed using conven-
tional techniques [27]. Briefly, membrane and synaptic
potentials were recorded from endplate regions, at room
temperature (22°C), with intracellular microelectrodes
filled with 3 M KCl (8–12 MΩ resistance), or with extra-
cellular microelectrodes (filled with Krebs-Ringer solu-
tion, 1–3 MΩ resistance) and an Axoclamp-2A system
(Axon Instruments, Foster City, CA, USA). Electrical sig-
nals after amplification were displayed on a digital oscil-
loscope, collected and digitized at a sampling rate of 25
kHz with the aid of a PC computer and a Digidata 1322A
unit (Axon Instruments). Computerized data acquisition
and analysis was performed with the program WinWCP
(V3.8), provided by Dr John Dempster (University of
Strathclyde, Strathclyde, Scotland). The motor nerve of
isolated neuromuscular preparations was stimulated via a
suction microelectrode, adapted to the diameter of the
nerve, with square wave pulses of 0.1 ms duration, gener-
ated by a S-44 stimulator (Grass Instruments, AstroMed,
W. Warwick, RI, USA), and supramaximal intensity (typi-
cally 3–8 V). Studies on EPPs were performed in standard
physiological solution containing 1.6 μM  μ-conotoxin
Conus Geographus (GIIIB) (Alomone Labs, Jerusalem,
Israel) to block voltage-dependent sodium channels of
skeletal muscle fibres [36]. The amplitudes of full-sized
EPPs and MEPPs recorded on junctions treated with μ-
conotoxin GIIIB were normalized to a membrane poten-
tial of -75 mV. MEPPs and EPPs were analysed individu-
ally for amplitude and time course. For each condition
studied, four to six individual experiments were per-
formed and the results were averaged to give the presented
mean ± s.e.m. The statistical significance of differences
between controls and test values was assessed with Stu-
dent's  t-Test (two-tailed), or the Kolmogorov-Smirnov
two-sample test. Differences were considered significant if
P < 0.05.
Biochemistry
DmAChE was produced in the baculovirus system and
purified as previously described [37]. The native human
AChE and BChE used for kinetic studies were from Sigma
Chemical Co. (St Louis, MO, USA). Hydrolysis of ATCh
was measured spectrophotometrically at 412 nm by the
Ellman method [38] at 25°C, in 25 mM phosphate buffer,
pH 7. Substrate concentrations were 4 μM-200 mM, with
a minimum of five repetitions per concentration. Activity
was followed for 1 min after addition of the enzyme to the
mixture and spontaneous hydrolysis of the substrate was
subtracted. Rates of carbamoylation were estimated by
incubation of AChEs with various concentrations of pro-
poxur for different periods of time. The remaining activity
was measured for 30 sec following 10-fold dilutions in
Ellman reaction medium supplemented with 1 mM
acetylthiocholine. Data were analysed using the model
and equation of Stojan and colleagues [39] for ATCh
hydrolysis inhibition and using the model of pseudo first
order irreversible inhibition for carbamoylation rate. Fits
were performed simultaneously on both equations by
multiple non-linear regressions using the program GOSA
[33].
Molecular docking of deet into AChE
The accommodation and binding of deet inside the active
site of HuAChE was made by building a 3D structure of
deet using MOLDEN, a processing program of molecular
and electronic structure, and then optimized quantum
mechanically in vacuo by Gaussian 03, an electronic struc-
ture program. For the calculation we used 6–31 g* basis
set at the Hartree-Fock level. For molecular mechanics,
energy and dynamic calculations we assigned atomic
types for the deet molecule already existing in the
CHARMM distribution C27n1 topology file. Charges were
calculated by Mullikan's approximation and the missing
parameters were searched until a satisfactory fit of the
model to the ab initio energy potentials and geometry was
obtained.
In the next step we manually docked the deet in the active
site above the catalytic serine (S203) of the HuAChE mol-
ecule: the appropriate three atoms of deet were superim-
posed on the corresponding atoms of substrate analogue
molecule situated in the active site of torpedo AChE (PDB
code 2C5F) with the carbonyl oxygen pointing into the
oxyanion hole. The structure was then fully relaxed with-
out moving any of the protein atoms. Finally, our 3D
model of HuAChE and docked deet was subjected to two
successive 50-step QMMM refinements, assigning the deet
molecule, catalytic serine (S203) and histidine (H447)BMC Biology 2009, 7:47 http://www.biomedcentral.com/1741-7007/7/47
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quantum mechanically (49 QM atoms and two link
atoms), while the rest of protein and water molecules
(193 of them) were treated mechanically. During QMMM
relaxation of the complex between HuAChE and the deet
molecule, the latter was accommodated in a tetrahedral
adduct conformation.
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